Skip to Content

Erbitux Injection 5mg/ml 20/ml 1 Vial

(0 review)

Erbitux Injection 5mg/ml 20ml 1 Vial contains Cetuximab, a targeted cancer therapy known as a monoclonal antibody. It is used in the treatment of certain cancers, especially metastatic colorectal cancer and head and neck cancers. Erbitux works by targeting and blocking the epidermal growth factor receptor (EGFR), which plays a key role in cancer cell growth and spread.

By blocking EGFR, Erbitux helps slow down tumor progression and may enhance the effectiveness of chemotherapy or radiotherapy when used in combination treatment plans. It is administered only as an intravenous (IV) infusion in a hospital or oncology center under strict medical supervision.

Erbitux is used based on the patient’s cancer type, stage, and EGFR status, and is always part of a specialized treatment protocol designed by an oncologist.

Uses

  • Metastatic colorectal cancer
  • Head and neck squamous cell carcinoma
  • EGFR-positive cancers (as determined by oncologist)
  • Combination therapy with chemotherapy or radiotherapy
  • Advanced cancer management under specialist care

Benefits

  • Targets cancer cells specifically (EGFR inhibition)
  • Helps slow tumor growth and spread
  • May improve survival outcomes in eligible patients
  • Enhances effectiveness of other cancer treatments
  • Administered under controlled medical supervision

Dosage

  • Must be given only by an oncologist or trained healthcare professional
  • Administered as a slow IV infusion
  • Dose depends on body weight, cancer type, and treatment protocol
  • Never self-administer or adjust dosage
  • Treatment schedule varies per patient condition

Prescription Required: Yes

How It Works

Cetuximab binds to the EGFR (Epidermal Growth Factor Receptor) on cancer cells. This blocks signals that stimulate cancer cell division and survival, helping to slow tumor growth and allow the immune system and other treatments to work more effectively.

Common Side Effects

  • Skin rash (acne-like eruption)
  • Fever and chills
  • Fatigue
  • Nausea and vomiting
  • Headache
  • Diarrhea
  • Infusion-related reactions
  • Low magnesium levels

Serious allergic or infusion reactions require immediate medical attention.

Do Not Use If

  • You are allergic to Cetuximab or any component of the injection
  • You have severe hypersensitivity to monoclonal antibodies
  • Not recommended without oncologist supervision
  • Patient condition does not meet EGFR-targeted therapy criteria

Storage Instructions

Store in a refrigerator at 2°C to 8°C. Do not freeze. Keep in original packaging and protect from light. Keep out of reach of children.

Price in Pakistan

The price of Erbitux Injection 5mg/ml 20ml 1 Vial in Pakistan generally ranges from Rs. 25,000 to Rs. 33,000 per vial, depending on the pharmacy, import source, and availability.

FAQs

Q1: What is Erbitux Injection used for?

It is used for head and neck cancers and metastatic colorectal cancer.

Q2: Is Erbitux chemotherapy?

No. It is a targeted monoclonal antibody therapy, not traditional chemotherapy.

Q3: Can Erbitux be used at home?

No. It must be administered in a hospital under specialist supervision.

Q4: How does Erbitux work?

It blocks EGFR receptors to stop cancer cell growth.

Q5: Is a prescription required?

Yes. Erbitux is a prescription-only oncology medicine.

28,500.00 Rs. 28,500.00 Rs. PER Piece

Not for Sale in Your Region

Delivery Time:


🏙️ Karachi: Mon-Sat: Same day (before 6 PM) 
                      Sunday: Closed


🚚 Other Cities: 24 – 72 hrs


📝Based on order time, area & item availability*✅

Erbitux Injection 5mg/ml 20ml 1 Vial contains Cetuximab, a targeted cancer therapy known as a monoclonal antibody. It is used in the treatment of certain cancers, especially metastatic colorectal cancer and head and neck cancers. Erbitux works by targeting and blocking the epidermal growth factor receptor (EGFR), which plays a key role in cancer cell growth and spread.

By blocking EGFR, Erbitux helps slow down tumor progression and may enhance the effectiveness of chemotherapy or radiotherapy when used in combination treatment plans. It is administered only as an intravenous (IV) infusion in a hospital or oncology center under strict medical supervision.

Erbitux is used based on the patient’s cancer type, stage, and EGFR status, and is always part of a specialized treatment protocol designed by an oncologist.

Uses

  • Metastatic colorectal cancer
  • Head and neck squamous cell carcinoma
  • EGFR-positive cancers (as determined by oncologist)
  • Combination therapy with chemotherapy or radiotherapy
  • Advanced cancer management under specialist care

Benefits

  • Targets cancer cells specifically (EGFR inhibition)
  • Helps slow tumor growth and spread
  • May improve survival outcomes in eligible patients
  • Enhances effectiveness of other cancer treatments
  • Administered under controlled medical supervision

Dosage

  • Must be given only by an oncologist or trained healthcare professional
  • Administered as a slow IV infusion
  • Dose depends on body weight, cancer type, and treatment protocol
  • Never self-administer or adjust dosage
  • Treatment schedule varies per patient condition

Prescription Required: Yes

How It Works

Cetuximab binds to the EGFR (Epidermal Growth Factor Receptor) on cancer cells. This blocks signals that stimulate cancer cell division and survival, helping to slow tumor growth and allow the immune system and other treatments to work more effectively.

Common Side Effects

  • Skin rash (acne-like eruption)
  • Fever and chills
  • Fatigue
  • Nausea and vomiting
  • Headache
  • Diarrhea
  • Infusion-related reactions
  • Low magnesium levels

Serious allergic or infusion reactions require immediate medical attention.

Do Not Use If

  • You are allergic to Cetuximab or any component of the injection
  • You have severe hypersensitivity to monoclonal antibodies
  • Not recommended without oncologist supervision
  • Patient condition does not meet EGFR-targeted therapy criteria

Storage Instructions

Store in a refrigerator at 2°C to 8°C. Do not freeze. Keep in original packaging and protect from light. Keep out of reach of children.

Price in Pakistan

The price of Erbitux Injection 5mg/ml 20ml 1 Vial in Pakistan generally ranges from Rs. 25,000 to Rs. 33,000 per vial, depending on the pharmacy, import source, and availability.

FAQs

Q1: What is Erbitux Injection used for?

It is used for head and neck cancers and metastatic colorectal cancer.

Q2: Is Erbitux chemotherapy?

No. It is a targeted monoclonal antibody therapy, not traditional chemotherapy.

Q3: Can Erbitux be used at home?

No. It must be administered in a hospital under specialist supervision.

Q4: How does Erbitux work?

It blocks EGFR receptors to stop cancer cell growth.

Q5: Is a prescription required?

Yes. Erbitux is a prescription-only oncology medicine.

Recently Viewed Products

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.

Same Day Delivery in Karachi

Fast, smooth delivery

Easy Reorders, Smart Reminders

Never run out of your essentials again

Bilingual Convenience

English & Urdu support for all ages

Customer Care Support

Support that feels like a local pharmacy

Genuine and Authentic Products Only

No risks, no counterfeits

24 to 72 Hours Delivery All over Pakistan

Reliable, smooth delivery